Organon & Co
607 hedge funds and large institutions have $3.1B invested in Organon & Co in 2026 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 153 increasing their positions, 191 reducing their positions, and 73 closing their positions.
22% more capital inflows, than outflows
Capital inflows: $502M | Capital outflows: $411M
2.78% more ownership
Funds ownership: 83.32% → 86.11% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
5% less funds holding
Funds holding: 641 → 607 (-34)
16% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 73
20% less repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 191
57% less call options, than puts
Call options by funds: $29.4M | Put options by funds: $69.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$143M |
| 2 |
Soros Fund Management
New York
|
+$40.3M |
| 3 |
Pentwater Capital Management
Naples,
Florida
|
+$28.4M |
| 4 |
Millennium Management
New York
|
+$23.1M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$22.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$48.9M |
| 2 |
Private Management Group
Irvine,
California
|
-$40.9M |
| 3 |
Glazer Capital
New York
|
-$37.4M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$32.7M |
| 5 |
Goldman Sachs
New York
|
-$31.6M |
OGN Hedge Fund Activity: Q3 2026 in Review
607 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q3 2026, worth a combined $3.1B — up 5.4% from $2.94B a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of OGN and 61 opened new positions — a net loss of 12 holders — while 191 trimmed existing stakes and 153 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $143M. The largest seller was LSV Asset Management, cutting an estimated $48.9M.
- 607 institutional investors held Organon & Co (OGN) as of Q3 2026, down from 641 in Q2 2026.
- Funds reported $3.1B of Organon & Co stock for Q3 2026, up 5.4% quarter-over-quarter.
- 61 funds opened new Organon & Co positions in Q3 2026 and 73 closed out, a net change of -12 holders.
- The largest Organon & Co buyer in Q3 2026 was Fidelity International, an estimated $143M added.
- The largest Organon & Co seller in Q3 2026 was LSV Asset Management, an estimated $48.9M sold.
Based on aggregated 13F filings for Q3 2026.